Key facts: Rocket Lab (RKLB) Q2 strong; targets raised; Neutron Q4 2026
Rocket Lab (RKLB) reported Q2 revenue of about $234.1M, up 62% YoY, with a GAAP loss of $0.08 per share. The company said it has a record $2.36B backlog, about $2.2B cash, and non-GAAP gross margin of 41.5%. It raised Neutron delivery timing to Q4 2026 and analysts at Cantor Fitzgerald and Citizens lifted price targets to $122 and $130.
How this was made

The 30-second read
Why it matters
Q2 strength (revenue growth, record backlog, gross margin) plus additional launch deals can improve near-term visibility, while Neutron timing uncertainty can keep valuation sensitive to execution risk.
Market read
Fresh Q2 metrics and a Neutron delivery schedule update provide a concrete catalyst for RKLB positioning, tempered by CEO commentary on potential slippage.
What to watch
The summary cites a GAAP loss and after-hours share drop; traders may focus on cash burn trajectory and execution milestones rather than backlog alone.
Background
The piece is a brief recap of Rocket Lab’s Q2 performance and an update to Neutron rocket delivery timing, alongside analyst target changes.
Ticker impact
Rocket Lab reports Q2 revenue of about $234.1M, record backlog $2.36B, and raises Neutron delivery timing to Q4 2026.
Near-term upside bias with volatility, as timing uncertainty offsets the stronger backlog and margin metrics.
The article contains multiple fresh, company-specific datapoints (Q2 results, backlog/cash, new launch deals, and Neutron delivery window) plus a CEO timing caveat that can temper the market reaction.
Market effects
Signals continued demand and execution progress in commercial launch, potentially supporting sentiment across small/mid-cap space names.
Limited direct regional read-through; primarily US-listed small-cap space sentiment.
Moderate, as Neutron schedule updates can influence global launch competition expectations.
Counterpoint
Neutron schedule uncertainty (maiden flight could slip past 2026) may mean today’s raised delivery window is still not de-risked enough to sustain a rerating.
Key entities
- companyRocket Lab
Reports Q2 results and updates Neutron delivery timing to Q4 2026, with CEO noting maiden flight could slip past 2026.
- analyst_firmCantor Fitzgerald
Raised its price target to $122 citing Neutron progress.
- analyst_firmCitizens
Maintained/kept a $130 target after the results.


